Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Top Cited Papers
- 1 October 2006
- journal article
- review article
- Published by Wiley in European Journal of Inorganic Chemistry
- Vol. 2006 (20), 4003-4018
- https://doi.org/10.1002/ejic.200600723
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Coordination of 9-Ethylguanine to the Mixed-Ligand Compound α-[Ru(azpy)(bpy)Cl2] (azpy = 2-Phenylazopyridine and bpy = 2,2‘-Bipyridine). An Unprecedented Ligand Positional Shift, Correlated to the Cytotoxicity of This Type of [RuL2Cl2] (with L = azpy or bpy) ComplexInorganic Chemistry, 2004
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004
- Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl2(dexrazoxane) and cis-PtCl2(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186)Journal of Inorganic Biochemistry, 2004
- Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L=o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]JBIC Journal of Biological Inorganic Chemistry, 2004
- Nucleotide Cross‐Linking Induced by Photoreactions of Platinum(IV)–Azide ComplexesAngewandte Chemie-International Edition, 2003
- Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane)Electronic supplementary information (ESI) available: synthesis, 31P{1H}, 1H, 13C NMR characterisation and elemental analysis of 1 and 2. See http://www.rsc.org/suppdata/cc/b2/b210102e/Chemical Communications, 2002
- Investigation of metallodrug–protein interactions by size-exclusion chromatography coupled with inductively coupled plasma mass spectrometry (ICP-MS)Analytica Chimica Acta, 1999
- Anti-leukaemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388DDP sublineEuropean Journal Of Cancer, 1993
- Cis- and trans-dihalotetrakis(dimethyl sulfoxide)ruthenium(II) complexes (RuX2(DMSO)4; X = Cl, Br): synthesis, structure, and antitumor activityInorganic Chemistry, 1988